Chronic degeneration of dorsal raphe serotonergic neurons modulates cortical spreading depression: A possible pathophysiology of migraine

Journal of Neuroscience Research

Volumn 91, Issue 6, 2013, Pages 737-744

  Cui, Yilong ^a   Li, Qing Hua ^b   Yamada, Hisao ^c   Watanabe, Yasuyoshi ^a,b   Kataoka, Yosky ^a  

^a RIKEN   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cortical spreading depression; Dorsal raphe serotonergic neurons; Hyperexcitability; Migraine

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEMALE; MIGRAINE; NERVE CELL DEGENERATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SPREADING CORTICAL DEPRESSION;

ANIMALS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CORTICAL SPREADING DEPRESSION; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MIGRAINE DISORDERS; NERVE DEGENERATION; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONERGIC NEURONS;

EID: 84876464243     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23209     Document Type: Article

References (44)

1. Ambrosini A, Schoenen J. 2006. Electrophysiological response patterns of primary sensory cortices in migraine. J Headache Pain 7:377-388.
2. Anthony M, Hinterberger H, Lance JW. 1967. Plasma serotonin in migraine and stress. Arch Neurol 16:544-552.
3. Araneda R, Andrade R. 1991. 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40:399-412.
4. Aurora SK, Ahmad BK, Welch KM, Bhardhwaj P, Ramadan NM. 1998. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology 50:1111-1114.
5. Battelli L, Black KR, Wray SH. 2002. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology 58:1066-1069.
6. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs HJr. 1991. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265:2831-2835.
7. Chen WT, Lin YY, Fuh JL, Hamalainen MS, Ko YC, Wang SJ. 2011. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain 134:2387-2395.
8. Cui Y, Kataoka Y, Li QH, Yokoyama C, Yamagata A, Mochizuki-Oda N, Watanabe J, Yamada H, Watanabe Y. 2003. Targeted tissue oxidation in the cerebral cortex induces local prolonged depolarization and cortical spreading depression in the rat brain. Biochem Bioph Res Commun 300:631-636.
9. Curran DA, Hinterberger H, Lance JW. 1965. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 88:997-1010.
10. Diksic M, Sakai Y, Nishikawa M, Hamel E, Aube M. 2008. Female migraine patients exhibit lower brain serotonin (5-HT) synthesis interictally than female controls. Cephalalgia 28:440-440.
11. Eikermann-Haerter K, Moskowitz MA. 2008. Animal models of migraine headache and aura. Curr Opin Neurol 21:294-300.
12. Fabricius M, Akgoren N, Lauritzen M. 1995. Arginine nitric-oxide pathway and cerebrovascular regulation in cortical spreading depression. Am J Physiol Heart C 269:H23-H29.
13. 3H-PAT. Nature 305:140-142.
14. Hadjikhani N, del Rio MS, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RBH, Sorensen AG, Moskowitz MA. 2001. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98:4687-4692.
15. Hamel E. 2007. Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293-1300.
16. Hansen AJ, Zeuthen T. 1981. Extracellular ion concentrations during spreading depression and ischemia in the rat-brain cortex. Acta Physiol Scand 113:437-445.
17. Hoyer D, Engel G, Kalkman HO. 1985. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes-radioligand binding-studies with [H-3] 5-HT, [H-3] 8-OH-DPAT, (-) [I-125] Iodocyanopindolol, [H-3] Mesulergine and [H-3] Ketanserin. Eur J Pharmacol 118:13-23.
18. Jakab RL, Goldman-Rakic PS. 2000. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 417:337-348.
19. Jonsson G, Pollare T, Hallman H, Sachs C. 1978. Developmental plasticity of central serotonin neurons after 5, 7-dihydroxytryptamine treatment. Ann N Y Acad Sci 305:328-345.
20. Kataoka Y, Morii H, Imamura K, Cui Y, Kobayashi M, Watanabe Y. 2000. Control of neurotransmission, behaviour and development, by photo-dynamic manipulation of tissue redox state of brain targets. Eur J Neurosci 12:4417-4423.
21. Kaube H, Hoskin KL, Goadsby PJ. 1993. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol 109:788-792.
22. Kawa K. 1994. Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study. J Neurophysiol 71:1935-1947.
23. Kimball RW, Friedman AP, Vallejo E. 1960. Effect of serotonin in migraine patients. Neurology 10:107-111.
24. Kostowski W, Bidzinski A, Krzascik P, Szyndler J, Rok P, Kolomanska P, Wislowska A, Lehner M, Plaznik A. 2004. Age-dependent effects of 5, 7-dihydroxytryptamine on serotonin transporter in different brain areas in the rat. Polish J Pharmacol 56:383-389.
25. Lauritzen M. 1994. Pathophysiology of the migraine aura-the spreading depression theory. Brain 117:199-210.
26. Lauritzen M, Jorgensen MB, Diemer NH, Gjedde A, Hansen AJ. 1982. Persistent oligemia of rat cerebral-cortex in the wake of spreading depression. Ann Neurol 12:469-474.
27. Lauritzen M, Olsen TS, Lassen NA, Paulson OB. 1983. Changes in regional cerebral blood-flow during the course of classic migraine attacks. Ann Neurol 13:633-641.
28. Leao AAP. 1944. Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359-390.
29. Milner PM. 1958. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leao. Electroencephalogr Clin Neurol 10:705-705.
30. Mizuma H, Mizutani M, Nozaki S, Iizuka H, Tohyama H, Nishimura N, Watanabe Y, Kohashi R. 2003. Improvement by repeated administration of 6R-tetrahydrobiopterin of 5, 7-dihydroxytryptamine-induced abnormal behaviors in immature rats. Biochem Biophys Res Commun 302:156-161.
31. Moskowitz MA, Buzzi MG. 1991. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 238(Suppl 1):S18-S22.
32. Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ. 2002. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol 9:35-40.
33. Nedergaard M, Hansen AJ. 1988. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res 449:395-398.
34. Olesen J, Larsen B, Lauritzen M. 1981. Focal hyperemia followed by spreading oligemia and impaired activation of Rcbf in classic migraine. Ann Neurol 9:344-352.
35. Park DH, Stone DM, Baker H, Wessel TC, Kim KS, Towle AC, Joh TH. 1993. Changes in activity and mRNA for rat tryptophan hydroxylase and aromatic L-amino acid decarboxylase of brain serotonergic cell bodies and terminals following neonatal 5, 7-dihydroxytryptamine. Brain Res 609:59-66.
36. Puig MV, Celada P, Diaz-Mataix L, Artigas F. 2003. In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cereb Cortex 13:870-882.
37. Puig MV, Artigas F, Celada P. 2005. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex 15:1-14.
38. Roerig B, Katz LC. 1997. Modulation of intrinsic circuits by serotonin 5-HT3 receptors in developing ferret visual cortex. J Neurosci 17:8324-8338.
39. Sachs C, Jonsson G. 1975. 5, 7-Dihydroxytryptamine induced changes in the postnatal development of central 5-hydroxytryptamine neurons. Med Biol 53:156-164.
40. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. 2003. Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 114:955-972.
41. Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel RD, Munz DL, Arnold G. 2007. Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 254:789-796.
42. Sicuteri F, Cossio M. 1961. Serotonin antagonists of lysergic origin in epilepsy. Riv Neurol 31:493-495.
43. Towle AC, Breese GR, Mueller RA, Coyle S, Lauder JM. 1984. Early postnatal administration of 5, 7-DHT-effects on serotonergic neurons and terminals. Brain Res 310:67-75.
44. Welch KM, D'Andrea G, Tepley N, Barkley G, Ramadan NM. 1990. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 8:817-828.